in

Acceleron Pharma Chief Medical Officer Matthew Sherman Retired

Xconomy: Acceleron Pharma Chief Medical Officer Sherman Plans Retirement

Xconomy Boston – Matthew Sherman, chief medical officer of Acceleron Pharma (NASDAQ: XLRN), plans to retire from the Cambridge, MA-based drug developer. Acceleron says Sherman won’t step away until after the company releases initial data from the Phase 3 study for luspatercept, a drug it is testing in partnership with Celgene (NASDAQ: CELG) as a treatment for a rare type of anemia.


Name: Matthew Sherman

Continent: North America

Country: USA

Company: Acceleron Pharma

Branch: Pharma

Position: Chief Medical Officer

Reason: Retired

Announcement Date: January 24, 2018, 11:00pm

Resignation Date: January 24, 2018, 11:00pm

Source 1: https://www.xconomy.com/boston/2018/01/25/acceleron-pharma-chief-medical-officer-sherman-plans-retirement/


Add your submission

Image Video Audio Text Embed

This field is required

Drop Images Here

or

You don't have javascript enabled. Media upload is not possible.

Get image from URL

Maximum upload file size: 10 MB.

Processing...

This field is required

Drop Video Here

or

You don't have javascript enabled. Media upload is not possible.

e.g.: https://www.youtube.com/watch?v=WwoKkq685Hk

Add

Supported services:

Maximum upload file size: 20 MB.

Processing...

This field is required

Drop Audio Here

or

You don't have javascript enabled. Media upload is not possible.

e.g.: https://soundcloud.com/community/fellowship-wrapup

Add

Supported services:

Maximum upload file size: 150 MB.

Processing...

This field is required

e.g.: https://www.youtube.com/watch?v=DWYrcnehito

Supported services:

Processing...

Report

What do you think?

Leave a Reply